FH Finnegan, Henderson, Farabow, Garrett & Dunner, LLP More Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Aaron Capron
USPTO Tightens “Unintentional Delay” Petitions — 1-Year Time Period Now Triggers Heightened Scrutiny
USPTO Tightens “Unintentional Delay” Petitions — 1-Year Time Period Now Triggers Heightened Scrutiny
For publication in the Federal Register of June 24, 2026, having an effective of August 13, 2026, the USPTO is issuing a final rule to significantly tighten its review of petitions based on “unintentional delay.” For petitions filed on or after August 13, 2026, the USPTO will require additional evidentiary support—and impose higher fees—for petitions filed more than one year after a missed deadline, replacing the prior two-year threshold.
When Engineering Meets Law: Aaron Capron's IP Odyssey
Finnegan partner Aaron Capron chats with IP journalist Steve Brachmann of IP Innovators about his unconventional path from Lockheed's GPS labs to leading one of the busiest patent prosecution teams in the U.S. IP Innovators is a podcast series that features in-depth conservations with leading patent practitioners, highlighting their career journeys and how technological advances are reshaping the way they practice law. Click here to listen to the episode.
What Do Patent Drafting And Jell-O™ Have In Common?
Predictive Challenges: Drafting a patent application needs foresight, as it is tough to predict how prior art might be applied by Examiners and ensure the application is future proof, given that amendments are often necessary. EPO's Strict Standards: The European Patent Office applies a strict standard requiring that any amendments must be directly and unambiguously derivable from the application as filed, almost demanding a literal basis for such amendments.
Progress Preempted: A Call To Restore The Cornerstone Of § 101
For over a decade since the Supreme Court's Alice decision, questions of patent eligibility have plagued the US patent system. The Federal Circuit has been burdened with development of subject matter eligibility law, due to the inability of Congress to pass legislature, and the refusal of the Supreme Court to address subject matter eligibility since Alice.
Progress preempted: A call to restore the cornerstone of § 101
(March 14, 2025) - Finnegan attorneys Aaron Capron, Kai Rajan, Andrew Schneider and Leith Shafi explain some of the challenges involved in applying the current test for establishing patentable subject matter and provide some solutions. For over a decade since the Supreme Court's Alice decision, questions of patent eligibility have plagued the US patent system.
USPTO Issues Guidance Documents To Implement Final Fee Rules Effective On January 19, 2025
Beginning on January 19, 2025, the United States Patent and Trademark Office (USPTO) will be implementing the new patent fees as published in the final rule on November 20, 2024 (89 Fed. Reg. 91898). In addition to the many across-the-board fee increases, there are some fees and required statements completely new to patent prosecution before the USPTO. Fortunately, the USPTO has provided three guidance documents to assist users in understanding and navigating the new fee schedule.
USPTO's AI Guidance: Where Is The Abstract Idea Analysis?
Is the claim as a whole directed to an abstract idea? Based on the Alice decision, that is the central question that courts ask themselves in determining whether a claim is patent-eligible under 35 U.S.C. § 101. As indicated in Alice, the Supreme Court's primary concern was that claims covering an abstract idea “would pre-empt use ...
USPTO's AI guidance: Where is the abstract idea analysis?
(September 20, 2024) - Finnegan, Henderson, Farabow, Garrett & Dunner LLP attorneys Aaron Capron, Adam Boger, Kai Rajan and Andrew Schneider explain how recent government guidance for evaluating the patent eligibility of artificial intelligence inventions appears inconsistent with case law. Is the claim as a whole directed to an abstract idea?
USPTO's AI Guidance: Where Is the Abstract Idea Analysis?
Is the claim as a whole directed to an abstract idea? Based on the Alice decision, that is the central question that courts ask themselves in determining whether a claim is patent-eligible under 35 U.S.C. § 101. As indicated in Alice, the Supreme Court's primary concern was that claims covering an abstract idea "would pre-empt use ...
Navigating Patent Eligibility In Digital Healthcare - Intellectual Property - United States
United States: Navigating Patent Eligibility In Digital Healthcare 30 June 2021 by Linda J. Thayer (Washington, DC) , Aaron Capron (Washington, DC) and Sneha Nyshadham (Washington, DC) Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com. Digital healthcare technologies are transforming the healthcare industry and quickly changing the way healthcare is delivered.
Navigating patent eligibility in digital healthcare
Poptika / Shutterstock.com Patent applicants with digital health inventions need to remember that being useful and novel may not be enough, warn Linda Thayer, Aaron Capron and Sneha Nyshadham of Finnegan, Henderson, Farabow, Garrett & Dunner. Digital healthcare technologies are transforming the healthcare industry and quickly changing the way healthcare is delivered.
Federal Circuit set to hear key patent eligibility case with far reaching consequences for hybrid technologies
06 Oct 2019 @IAM_magazine The IAM Sunday Supplement has been published. It details everything that ran on the IAM platform last week to set y… https://t.co/CZApFtYPEt Read more 06 Oct 2019 @IAM_magazine RT @MelanieConroy1: Big news from France.
Federal Circuit set to hear key patent eligibility case with far reaching consequences for hybrid technologies
01 Oct 2019 @IAM_magazine All September’s big biopharma patent policy, litigation and deals news in the IAM monthly round-up.… https://t.co/Ao43Af7UYY Read more 01 Oct 2019 @IAM_magazine RT @Battelle: Our Sr Dir of IP & Tech Commercialization Vicki Barbur speaks at @IAM_magazine's patent licensing event Oct. 3.
Lessons Learned from 23andMe Inc. v Ancestry.com
Medical device innovators should pay attention to the recent court case for clues on how courts could view other hybrid inventions such as wearables and more. The current trajectory of innovation is resulting in the convergence of biological and electronic discoveries into hybrid technologies that incorporate aspects of both scientific disciplines.
Ex Parte Re-exams: Don’t You Forget About Me
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Already signed up? Log in here By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
[Webinar] Software as a Medical Device (SaMD): What It Is and How Can We Protect Our Related IP? - January 31st, 10:00am PT
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Already signed up? Log in here By using the service, you signify your acceptance of JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Aaron
Contact Aaron, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack